Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(21 sites)
United States
Children's Hospital Colorado, Aurora, Colorado Children's National Medical Center, Washington D.C., District of Columbia Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois Dana-Farber Cancer Institute, Boston, Massachusetts Duke University Health System, Durham, North Carolina Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio Nationwide Children's Hospital, Columbus, Ohio Children's Hospital of Philadelphia, Philadelphia, Pennsylvania Texas Children's Hospital, Houston, Texas Seattle Children's Hospital, Seattle, Washington Australia
Sydney Children's Hospital, Randwick, New South Wales Queensland Children's Hospital, South Brisbane, Queensland Perth Children's Hospital, Perth, Western Australia Canada
The Hospital for Sick Children (SickKids), Toronto, Ontario Montreal Children's Hospital, Montreal, Quebec Germany
Hopp Children's Cancer Center at NCT Heidelberg (KiTZ), Heidelberg, Baden-Wurttemberg University Medical Center Augsburg, Augsburg University Hospital Berlin, Berlin University Hospital Koln, Cologne University Medical Center Gottingen, Göttingen New Zealand
Starship Children's Hospital, Auckland, Grafton